John Wayne Cancer Institute
Neurology
Dr. Santosh Kesari, MD
|
|
Give Review
Doctor Santosh Kesari, MD is an expert in the field of Neurology. He graduated from Harvard Medical School. Harvard Medical School is one of the top medical schools in the US. Harvard Medical School is ranked 1/12 in Research/PrimaryCare. He over the years received 25 awards: "America's Top Doctors", "Top Doctors:San Diego Area", "America's Top Doctors for Cancer", "Top Doctors:Southern California", "Innovation Awards, Medical Research, San Diego Business Journal", "Castle Connolly Top Doctors: Southern California", "CMS Meaningful Use Stage 1 Certification", "Doc Star (Cancer)", "Finalist, Health Care Champions Award, Health Technology Innovations and Research", "U.S. News Top Doctors in Medical Oncology", "Overseas Executive Chairman, Chongqing International Neurological Forum", "Best Doctors in America", "Marquis Who's Who in America", "Gold Doc Award", "Marquis Who's Who in Science and Engineering", "Global Directory of Who's Who", "Sontag Foundation Distinguished Scientist Award", "Founders Award", "American Neurological Association Travel Award", "Dr. William A. Jeffers Prize, University of Pennsylvania", "American Society for Virology Student Travel Award", "NIH National Research Service Award", "Benjamin Franklin Scholar", "Pi Mu Epsilon National Mathematics Honor Society" and "Penn Medical Scholar". Santosh Kesari is a published doctor. He has 64 papers published. The most current publication "Leptomeningeal metastasis in breast cancer - a systematic review." He accepts all Medicare patients.
Publications
- Leptomeningeal metastasis in breast cancer - a Systematic review.
- Multiple spatially related pharmacophores define small molecule inhibitors of OLIG2 in glioblastoma.
- A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study.
- Hierarchical control of coherent gene clusters defines the molecular mechanisms of glioblastoma.
- A Phase I trial of high dose gefitinib for patients with leptomeningeal metastases from non-small cell lung Cancer.
- Glucose-corrected standardized uptake value in the differentiation of high-grade glioma versus post-treatment changes.
- Combining diffusion and perfusion differentiates tumor from bevacizumab-related imaging Abnormality (bria).
- Phase 2 study of CT-322, a targeted biologic inhibitor of VEGFR-2 based on a domain of human fibronectin, in recurrent glioblastoma.
- Mitochondrial p32 is upregulated in Myc expressing Brain cancers and mediates glutamine addiction.
- In vitro and in vivo antiCancer effects of mevalonate pathway modulation on human Cancer cells.
- Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging.
- Bevacizumab: radiation combination produces restricted diffusion on Brain MRI.
- Retrospective analysis of safety and feasibility of a 3 days on/11 days off temozolomide dosing regimen in recurrent adult malignant Gliomas.
- Concurrent intrathecal methotrexate and liposomal cytarabine for leptomeningeal metastasis from solid Tumors: a retrospective cohort study.
- bHLHTranscription Factors Inhibitors For Cancer Therapy: General Features For InSilico Drug Design.
- Targeting and depletion of circulating leukocytes and Cancer cells by lipophilic antibody-modified erythrocytes.
- Distearoyl anchor-Painted erythrocytes with prolonged ligand retention and circulation properties in vivo.
- The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: A potential therapeutic opportunity for atherosclerotic Thrombosis.
- Clinical trials of viral therapy for malignant Gliomas.
- 78 year old male with dysphagia and dysarthria.
- PTEN status mediates 2ME2 anti-tumor efficacy in preclinical glioblastoma models: role of HIF1α suppression.
- Retrospective analysis of the tolerability and activity of lacosamide in patients with Brain tumors: clinical article.
- Direct Recognition of Superparamagnetic Nanocrystals by Macrophage Scavenger Receptor SR-AI.
- Glucose corrected standardized uptake value (SUVgluc) in the evaluation of Brain lesions with 18F-FDG PET.
- Longitudinal Restriction Spectrum Imaging Is Resistant to Pseudoresponse in Patients with High-Grade Gliomas Treated with Bevacizumab.
- Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles.
- 47-year-old man with left leg numbness.
- High-resolution mutational profiling suggests the genetic validity of glioblastoma patient-derived pre-clinical models.
- The blues of minocycline.
- Recovery of White Matter Tracts in Regions of Peritumoral FLAIR Hyperintensity With Use of Restriction Spectrum Imaging.
- Improved Conspicuity and Delineation of High-Grade Primary and Metastatic Brain Tumors Using "Restriction Spectrum Imaging": Quantitative Comparison with High B-Value ...
- Cerebellar glioneuronal tumor: a case report and review of the literature.
- Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors.
- Brain metastasis from ovarian cancer: case report and review of the literature.
- Durable remission of leptomeningeal metastases from hormone-responsive prostate Cancer.
- Cardioembolic stroke following a fractured transseptal wire.
- Erratum to: Multifocal CNS infiltration of chronic lymphocytic leukemia in the form of small-cell solid metastatic lesions.
- Multifocal CNS infiltration of chronic lymphocytic leukemia in the form of small-cell solid metastatic lesions.
- Sellar and supra-sellar glioblastoma masquerading as a pituitary macroadenoma.
- 55-YEAR-OLD FEMALE WITH LOW Back PAIN.
- Recognition of Dextran-Superparamagnetic Iron Oxide Nanoparticle Conjugates (Feridex) via Macrophage Scavenger Receptor Charged Domains.
- Radiation induced myelopathy in a patient with tongue Cancer: a case report.
- Rituximab for tumefactive Inflammatory demyelination: A case report.
- MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect Disease activity.
- Tcf7l2 is tightly controlled during myelin formation.
- Temporal changes in magnetic resonance imaging characteristics of Gliadel wafers and of the adjacent Brain parenchyma.
- Neoplastic meningitis resulting from hematological malignancies: pharmacokinetic considerations and maximizing outcome.
- Decompensated chronic congenital Hydrocephalus.
- Late temporal lobe necrosis after conventional radiotherapy for carcinoma of maxillary sinus.
- The molecular basis for novel therapies.
- Levetiracetam-induced interstitial nephritis in a patient with glioma.
- Paraganglioma with intraCranial metastasis: a case report and review of the literature.
- Cerebral syphilitic gumma: a case report and review of the literature.
- Patterns of imaging failures in glioblastoma patients treated with chemoradiation: a retrospective study.
- Understanding glioblastoma tumor biology: the potential to improve current diagnosis and treatments.
- miR-21 in the Extracellular Vesicles (EVs) of Cerebrospinal Fluid (CSF): A Platform for Glioblastoma Biomarker Development.
- Cancer anti-angiogenesis vaccines: Is the tumor vasculature antigenically unique?
- In silico modeling predicts drug sensitivity of patient-derived Cancer cells.
- Induction of tumor inhibitory anti-angiogenic response through immunization with interferon Gamma primed placental endothelial cells: ValloVax™.
- Restriction-Spectrum Imaging of Bevacizumab-Related Necrosis in a Patient with GBM.
- High-efficiency liposomal encapsulation of a tyrosine kinase inhibitor leads to improved in vivo Toxicity and tumor response profile.
- Novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
- Correction: novel anti-glioblastoma agents and therapeutic combinations identified from a collection of FDA approved drugs.
Schools
Perelman School of Medicine University of Pennsylvania
Beth Israel Deaconess Med Center
Ma Gen HospBrigham and Womens Hospital
Dana Faber Cancer Institute
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Brain and Nervous Background: yellow;'>System Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Background: yellow;'>Cancer (incl. Background: yellow;'>Background: yellow;'>Background: yellow;'>Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:San Diego Area
- America's Top Doctors for Cancer
- Top Doctors:Southern California
- Innovation Awards, Medical Research, San Diego Business Journal
- Castle Connolly Top Doctors: Southern California
- CMS Meaningful Use Stage 1 Certification
- Doc Star (Cancer)
- Finalist, Health Care Champions Award, Health Technology Innovations and Research
- U.S. News Top Doctors in Medical Oncology
- Overseas Executive Chairman, Chongqing International Neurological Forum
- Best Doctors in America
- Marquis Who's Who in America
- Gold Doc Award
- Marquis Who's Who in Science and Engineering
- Global Directory of Who's Who
- Sontag Foundation Distinguished Scientist Award
- Founders Award
- American Neurological Association Travel Award
- Dr. William A. Jeffers Prize, University of Pennsylvania
- American Society for Virology Student Travel Award
- NIH National Research Service Award
- Benjamin Franklin Scholar
- Pi Mu Epsilon National Mathematics Honor Society
- Penn Medical Scholar
Education
-
Harvard School of Public Health -
Harvard Medical School -
Massachusetts General Hospital -
Beth Israel Deaconess Medical Center -
Perelman School of Medicine at the University of Pennsylvania -
University of Pennsylvania School of Medicine
Hospital
-
UC San Diego Health
Drug Facts
| NPI NUMBER | 1891785960 | |
| NPPES Provider LastName | KESARI | |
| NPPES Provider FirstName | SANTOSH | |
| NPPES Provider ZIPCode | 920930819 | |
| NPPES Provider State | CA | |
| Specialty Description | Neurology | |
| Total Claim Count | 200.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1891785960 |
| Last Name Of The Provider | KESARI |
| First Name Of The Provider | SANTOSH |
| View All |
Similar Doctors
|
|
Dr. Dee E. Silver, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David S. Michelson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nelson Hwynn, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J S. Poceta, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David E. Piccioni, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John A. Aalbers, MD |
|
|
Dr. Douglas R. Galasko, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shirley M. Otis, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa K. Houser, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick J. De La Vega, MD |
|
|
Dr. Verena C. Haringer, MD |